MedTrace Logo

Safety and Effectiveness of Different ShangRing Device Sizes for Adult Male Circumcision in Lusaka, Zambia

NCT02242565 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2017-10-02

No results posted yet for this study

Summary

The purpose of this study was to assess the safety, effectiveness and acceptability of providing a reduced number of ShangRing sizes for adult voluntary medical male circumcision (VMMC) within routine service delivery in Lusaka, Zambia.

Conditions

  • Male Circumcision

Interventions

DEVICE

ShangRing

ShangRing device for male circumcision

Sponsors & Collaborators

  • Bill and Melinda Gates Foundation

    collaborator OTHER

  • Ministry of Health, Zambia

    collaborator OTHER_GOV

  • FHI 360

    lead OTHER

Principal Investigators

  • Robert Zulu, MD · University Teaching Hospital

  • Paul Feldblum, PhD · FHI 360

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2015-09-30
Completion
2015-12-31

Countries

  • Zambia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02242565 on ClinicalTrials.gov